Core Insights - The company achieved organic revenue growth of 13%, driven by new resident additions, increased script volumes, and a shift toward higher-acuity care [1] - Adjusted EBITDA margins expanded by 50 basis points despite the costs associated with becoming a public company and integrating early-stage acquisitions [1] - The company effectively managed challenges in the branded inhaler category due to the American Rescue Plan through disciplined operational execution [1] Clinical and Operational Highlights - Clinical value was demonstrated through over 100,000 interventions and an insurance optimization program that saved residents approximately $56 million [1] - Management credits its competitive advantage to a local service model that alleviates labor burdens for facility operators facing an aging population [1] - Strategic investments in 'Guardian Hub' and 'Guardian Note' messaging systems have enhanced real-time visibility and workflow efficiency for facility partners [1] Financial Strategy - The company maintains a disciplined capital allocation strategy, leveraging strong cash flow to fund four acquisitions and multiple greenfield startups without the need for external financing [1]